Global AI Drug Development Platform Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06259291

Publication Date:

June 26, 2025

Pages:

149

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global AI Drug Development Platform market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for AI Drug Development Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for AI Drug Development Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for AI Drug Development Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key AI Drug Development Platform players cover Insilico Medicine, MindRank, BenevolentAI, Exscientia, Deep Pharma Intelligence, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淎I Drug Development Platform Industry Forecast鈥� looks at past sales and reviews total world AI Drug Development Platform sales in 2024, providing a comprehensive analysis by region and market sector of projected AI Drug Development Platform sales for 2025 through 2031. With AI Drug Development Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Drug Development Platform industry.
This Insight Report provides a comprehensive analysis of the global AI Drug Development Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI Drug Development Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global AI Drug Development Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Drug Development Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Drug Development Platform.
This report presents a comprehensive overview, market shares, and growth opportunities of AI Drug Development Platform market by product type, application, key players and key regions and countries.
Segmentation by Type:
Software Provider Mode
CRO Service Mode
Self-Development Pipeline Mode
Segmentation by Application:
SMEs
Large Enterprises
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Insilico Medicine
MindRank
BenevolentAI
Exscientia
Deep Pharma Intelligence
Delta4
DNDi
Standigm
Genesis Therapeutics
Data2Discovery
Unlearn.AI
Deep Intelligent Pharma
CarbonSilicon AI Technology
XtalPi
Tencent
Fastone
Stonewise
HitGen
Galixir
Matwings Technology
Alibaba

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI Drug Development Platform Market Size (2020-2031)
2.1.2 AI Drug Development Platform Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for AI Drug Development Platform by Country/Region (2020, 2024 & 2031)
2.2 AI Drug Development Platform Segment by Type
2.2.1 Software Provider Mode
2.2.2 CRO Service Mode
2.2.3 Self-Development Pipeline Mode
2.3 AI Drug Development Platform Market Size by Type
2.3.1 AI Drug Development Platform Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global AI Drug Development Platform Market Size Market Share by Type (2020-2025)
2.4 AI Drug Development Platform Segment by Application
2.4.1 SMEs
2.4.2 Large Enterprises
2.5 AI Drug Development Platform Market Size by Application
2.5.1 AI Drug Development Platform Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global AI Drug Development Platform Market Size Market Share by Application (2020-2025)
3 AI Drug Development Platform Market Size by Player
3.1 AI Drug Development Platform Market Size Market Share by Player
3.1.1 Global AI Drug Development Platform Revenue by Player (2020-2025)
3.1.2 Global AI Drug Development Platform Revenue Market Share by Player (2020-2025)
3.2 Global AI Drug Development Platform Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI Drug Development Platform by Region
4.1 AI Drug Development Platform Market Size by Region (2020-2025)
4.2 Global AI Drug Development Platform Annual Revenue by Country/Region (2020-2025)
4.3 Americas AI Drug Development Platform Market Size Growth (2020-2025)
4.4 APAC AI Drug Development Platform Market Size Growth (2020-2025)
4.5 Europe AI Drug Development Platform Market Size Growth (2020-2025)
4.6 Middle East & Africa AI Drug Development Platform Market Size Growth (2020-2025)
5 Americas
5.1 Americas AI Drug Development Platform Market Size by Country (2020-2025)
5.2 Americas AI Drug Development Platform Market Size by Type (2020-2025)
5.3 Americas AI Drug Development Platform Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Drug Development Platform Market Size by Region (2020-2025)
6.2 APAC AI Drug Development Platform Market Size by Type (2020-2025)
6.3 APAC AI Drug Development Platform Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI Drug Development Platform Market Size by Country (2020-2025)
7.2 Europe AI Drug Development Platform Market Size by Type (2020-2025)
7.3 Europe AI Drug Development Platform Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI Drug Development Platform by Region (2020-2025)
8.2 Middle East & Africa AI Drug Development Platform Market Size by Type (2020-2025)
8.3 Middle East & Africa AI Drug Development Platform Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI Drug Development Platform Market Forecast
10.1 Global AI Drug Development Platform Forecast by Region (2026-2031)
10.1.1 Global AI Drug Development Platform Forecast by Region (2026-2031)
10.1.2 Americas AI Drug Development Platform Forecast
10.1.3 APAC AI Drug Development Platform Forecast
10.1.4 Europe AI Drug Development Platform Forecast
10.1.5 Middle East & Africa AI Drug Development Platform Forecast
10.2 Americas AI Drug Development Platform Forecast by Country (2026-2031)
10.2.1 United States Market AI Drug Development Platform Forecast
10.2.2 Canada Market AI Drug Development Platform Forecast
10.2.3 Mexico Market AI Drug Development Platform Forecast
10.2.4 Brazil Market AI Drug Development Platform Forecast
10.3 APAC AI Drug Development Platform Forecast by Region (2026-2031)
10.3.1 China AI Drug Development Platform Market Forecast
10.3.2 Japan Market AI Drug Development Platform Forecast
10.3.3 Korea Market AI Drug Development Platform Forecast
10.3.4 Southeast Asia Market AI Drug Development Platform Forecast
10.3.5 India Market AI Drug Development Platform Forecast
10.3.6 Australia Market AI Drug Development Platform Forecast
10.4 Europe AI Drug Development Platform Forecast by Country (2026-2031)
10.4.1 Germany Market AI Drug Development Platform Forecast
10.4.2 France Market AI Drug Development Platform Forecast
10.4.3 UK Market AI Drug Development Platform Forecast
10.4.4 Italy Market AI Drug Development Platform Forecast
10.4.5 Russia Market AI Drug Development Platform Forecast
10.5 Middle East & Africa AI Drug Development Platform Forecast by Region (2026-2031)
10.5.1 Egypt Market AI Drug Development Platform Forecast
10.5.2 South Africa Market AI Drug Development Platform Forecast
10.5.3 Israel Market AI Drug Development Platform Forecast
10.5.4 Turkey Market AI Drug Development Platform Forecast
10.6 Global AI Drug Development Platform Forecast by Type (2026-2031)
10.7 Global AI Drug Development Platform Forecast by Application (2026-2031)
10.7.1 GCC Countries Market AI Drug Development Platform Forecast
11 Key Players Analysis
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Information
11.1.2 Insilico Medicine AI Drug Development Platform Product Offered
11.1.3 Insilico Medicine AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Insilico Medicine Main Business Overview
11.1.5 Insilico Medicine Latest Developments
11.2 MindRank
11.2.1 MindRank Company Information
11.2.2 MindRank AI Drug Development Platform Product Offered
11.2.3 MindRank AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 MindRank Main Business Overview
11.2.5 MindRank Latest Developments
11.3 BenevolentAI
11.3.1 BenevolentAI Company Information
11.3.2 BenevolentAI AI Drug Development Platform Product Offered
11.3.3 BenevolentAI AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 BenevolentAI Main Business Overview
11.3.5 BenevolentAI Latest Developments
11.4 Exscientia
11.4.1 Exscientia Company Information
11.4.2 Exscientia AI Drug Development Platform Product Offered
11.4.3 Exscientia AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Exscientia Main Business Overview
11.4.5 Exscientia Latest Developments
11.5 Deep Pharma Intelligence
11.5.1 Deep Pharma Intelligence Company Information
11.5.2 Deep Pharma Intelligence AI Drug Development Platform Product Offered
11.5.3 Deep Pharma Intelligence AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Deep Pharma Intelligence Main Business Overview
11.5.5 Deep Pharma Intelligence Latest Developments
11.6 Delta4
11.6.1 Delta4 Company Information
11.6.2 Delta4 AI Drug Development Platform Product Offered
11.6.3 Delta4 AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Delta4 Main Business Overview
11.6.5 Delta4 Latest Developments
11.7 DNDi
11.7.1 DNDi Company Information
11.7.2 DNDi AI Drug Development Platform Product Offered
11.7.3 DNDi AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 DNDi Main Business Overview
11.7.5 DNDi Latest Developments
11.8 Standigm
11.8.1 Standigm Company Information
11.8.2 Standigm AI Drug Development Platform Product Offered
11.8.3 Standigm AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Standigm Main Business Overview
11.8.5 Standigm Latest Developments
11.9 Genesis Therapeutics
11.9.1 Genesis Therapeutics Company Information
11.9.2 Genesis Therapeutics AI Drug Development Platform Product Offered
11.9.3 Genesis Therapeutics AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Genesis Therapeutics Main Business Overview
11.9.5 Genesis Therapeutics Latest Developments
11.10 Data2Discovery
11.10.1 Data2Discovery Company Information
11.10.2 Data2Discovery AI Drug Development Platform Product Offered
11.10.3 Data2Discovery AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Data2Discovery Main Business Overview
11.10.5 Data2Discovery Latest Developments
11.11 Unlearn.AI
11.11.1 Unlearn.AI Company Information
11.11.2 Unlearn.AI AI Drug Development Platform Product Offered
11.11.3 Unlearn.AI AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Unlearn.AI Main Business Overview
11.11.5 Unlearn.AI Latest Developments
11.12 Deep Intelligent Pharma
11.12.1 Deep Intelligent Pharma Company Information
11.12.2 Deep Intelligent Pharma AI Drug Development Platform Product Offered
11.12.3 Deep Intelligent Pharma AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Deep Intelligent Pharma Main Business Overview
11.12.5 Deep Intelligent Pharma Latest Developments
11.13 CarbonSilicon AI Technology
11.13.1 CarbonSilicon AI Technology Company Information
11.13.2 CarbonSilicon AI Technology AI Drug Development Platform Product Offered
11.13.3 CarbonSilicon AI Technology AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 CarbonSilicon AI Technology Main Business Overview
11.13.5 CarbonSilicon AI Technology Latest Developments
11.14 XtalPi
11.14.1 XtalPi Company Information
11.14.2 XtalPi AI Drug Development Platform Product Offered
11.14.3 XtalPi AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 XtalPi Main Business Overview
11.14.5 XtalPi Latest Developments
11.15 Tencent
11.15.1 Tencent Company Information
11.15.2 Tencent AI Drug Development Platform Product Offered
11.15.3 Tencent AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Tencent Main Business Overview
11.15.5 Tencent Latest Developments
11.16 Fastone
11.16.1 Fastone Company Information
11.16.2 Fastone AI Drug Development Platform Product Offered
11.16.3 Fastone AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Fastone Main Business Overview
11.16.5 Fastone Latest Developments
11.17 Stonewise
11.17.1 Stonewise Company Information
11.17.2 Stonewise AI Drug Development Platform Product Offered
11.17.3 Stonewise AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Stonewise Main Business Overview
11.17.5 Stonewise Latest Developments
11.18 HitGen
11.18.1 HitGen Company Information
11.18.2 HitGen AI Drug Development Platform Product Offered
11.18.3 HitGen AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 HitGen Main Business Overview
11.18.5 HitGen Latest Developments
11.19 Galixir
11.19.1 Galixir Company Information
11.19.2 Galixir AI Drug Development Platform Product Offered
11.19.3 Galixir AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Galixir Main Business Overview
11.19.5 Galixir Latest Developments
11.20 Matwings Technology
11.20.1 Matwings Technology Company Information
11.20.2 Matwings Technology AI Drug Development Platform Product Offered
11.20.3 Matwings Technology AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Matwings Technology Main Business Overview
11.20.5 Matwings Technology Latest Developments
11.21 Alibaba
11.21.1 Alibaba Company Information
11.21.2 Alibaba AI Drug Development Platform Product Offered
11.21.3 Alibaba AI Drug Development Platform Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Alibaba Main Business Overview
11.21.5 Alibaba Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂